OX40 Ligand

OX40 Ligand 詳細

英語名Tumor necrosis factor ligand superfamily member 4市販薬剤の数0
治験薬の数13ターゲットの別称CD134L,OX-40L,TNLG2B,OX4OL,GP34,CD252 Antigen,CD134 Ligand,TAX transcriptionally-activated glycoprotein 1,Tax-Transcriptionally Activated Glycoprotein 1, 34kD,CD252,OX40 ligand,OX40L,TNFSF4,Tumor necrosis factor ligand superfamily member 4,Glycoprotein Gp34,TNF Superfamily Member 4,TXGP1,Tax-Transcriptionally Activated Glycoprotein 1 (34kD),Tumor Necrosis Factor (Ligand) Superfamily, Member 4,Tumor Necrosis Factor (Ligand) Superfamily Member 4,Tumor Necrosis Factor Superfamily Member 4,Tumor Necrosis Factor Ligand 2B,OX40 Antigen Ligand
研究&開発段階Phase 3 Clinical
英語名Tumor necrosis factor ligand superfamily member 4
ターゲットの別称CD134L,OX-40L,TNLG2B,OX4OL,GP34,CD252 Antigen,CD134 Ligand,TAX transcriptionally-activated glycoprotein 1,Tax-Transcriptionally Activated Glycoprotein 1, 34kD,CD252,OX40 ligand,OX40L,TNFSF4,Tumor necrosis factor ligand superfamily member 4,Glycoprotein Gp34,TNF Superfamily Member 4,TXGP1,Tax-Transcriptionally Activated Glycoprotein 1 (34kD),Tumor Necrosis Factor (Ligand) Superfamily, Member 4,Tumor Necrosis Factor (Ligand) Superfamily Member 4,Tumor Necrosis Factor Superfamily Member 4,Tumor Necrosis Factor Ligand 2B,OX40 Antigen Ligand
市販薬剤の数0
治験薬の数13
研究&開発段階Phase 3 Clinical

OX40 Ligandバックグランド

Tumor necrosis factor ligand superfamily member 4 (TNFSF4) is also known as glycoprotein Gp34, OX40 ligand (OX40L), TAX transcriptionally-activated glycoprotein 1 and CD252, which belongs to the tumor necrosis factor family. TNFSF4 is the ligand for CD134 and is expressed on such cells as DC2s (a subtype of dendritic cells) enabling amplification of Th2 cell differentiation. The interaction of TNFSF4-TNFSF4 is involved in the pathogenesis of multiple autoimmune and inflammatory diseases such as systemic lupus erythematosus (SLE), carotid artery disease and cancer. Furthermore, similar to other TNF superfamily members, membrane-bound OX40 Ligand (TNFSF4) exists as a homotrimer. Human TNFSF4 shares 46% amino acid sequence identity with its mouse counterpart.

OX40 Ligand分子の別称

OX40L,TNFSF4,CD252,Glycoprotein Gp34,TXGP1,CD134 ligand,CD134L

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
AmlitelimabKY-1005; SAR-445229Phase 3 ClinicalKymab Ltd, SanofiAlopecia Areata; Asthma; Celiac Disease; Dermatitis, Atopic; Eczema; Hidradenitis; Immune System Diseases; Lung Diseases, Interstitial; Scleroderma, Systemic
詳細
APG-279APG279; APG-990/APG777Phase 2 ClinicalApogee Therapeutics IncDermatitis, Atopic
詳細
IMB-101 (IMBiologics)IMB-101 (IMBiologics); HDM-3019; IMB101 (IMBiologics); HDM3019; NAV-240Phase 2 ClinicalIMBiologics CorpArthritis, Rheumatoid; Hidradenitis Suppurativa
詳細
IBI356IBI-356; IBI356Phase 2 ClinicalAutoimmune Diseases; Dermatitis, Atopic
詳細
RP-3RP-3Phase 2 ClinicalReplimune IncBiliary Tract Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
HS-130HS-130Phase 1 ClinicalHeat BiologicsSolid tumours
詳細
mRNA-2752mRNA-2752Phase 1 ClinicalAstrazeneca Plc, Moderna IncLymphoma; Neoplasms; Solid tumours
詳細
MQ-710MQ-710Phase 1 ClinicalImvaq Therapeutics Corp, Memorial Sloan Kettering Cancer CenterAdenocarcinoma, Sebaceous; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Hemangiosarcoma; Melanoma; Neoplasm Metastasis; Neoplasms; Paget Disease, Extramammary; Sarcoma, Kaposi; Solid tumours; Squamous Cell Carcinoma of Head and Neck
詳細
OX-118OX-118Phase 1 ClinicalOxion Biologics ABAutoimmune Diseases; Immune System Diseases; Rheumatic Diseases
詳細
M-5542M5542; M-5542Phase 1 ClinicalMerck & Co Inc
詳細
ABCL-575ABCL-575; ABCL575Phase 1 ClinicalAbCellera Biologics IncDermatitis, Atopic
詳細
APG-990APG-990; APG990; PR-007; PR007Phase 1 ClinicalParagon Therapeutics IncDermatitis, Atopic
詳細
SAR-443726SAR-443726Phase 1 ClinicalSanofiDermatitis, Atopic
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8